Medications

Japan first nation to approve Novartis psoriasis drug

Swiss pharmaceutical company Novartis said Friday it has won approval to market its Cosentyx psoriasis treatment in Japan, making it the first country to authorise commercialisation of the drug.

Medications

Psoriasis treatments can be life-changing

If you suffer from psoriasis, vibrant, clear skin is no longer out of reach. According to Rush dermatologists, new innovative treatments can help you put your best face forward.

Medications

Skyrizi approved for psoriatic arthritis

(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.

Arthritis & Rheumatism

Study lays foundation for new psoriasis treatment strategy

About 250,000 people in Austria suffer from psoriasis. One third of them develop inflammation in their joints (psoriatic arthritis) as a result of the chronic skin condition. As part of a study, a MedUni Vienna research team ...

page 3 from 14